Atlas Capital Advisors LLC 10x Genomics, Inc. Transaction History
Atlas Capital Advisors LLC
- $770 Billion
- Q2 2024
A detailed history of Atlas Capital Advisors LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 1,234 shares of TXG stock, worth $19,447. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,234
Previous 1,934
36.19%
Holding current value
$19,447
Previous $72.6 Million
66.93%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding TXG
# of Institutions
282Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$161 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$147 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$101 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$96.9 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$96.8 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.5B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...